tiprankstipranks
Biolidics Ltd. (SG:8YY)
SGX:8YY
Singapore Market
8YY
Biolidics Ltd.
RESEARCH TOOLSreports
Want to see SG:8YY full AI Analyst Report?

Biolidics Ltd. (8YY) Financial Statements

2 Followers

Biolidics Ltd. Financial Overview

Biolidics Ltd.'s market cap is currently S$88.41M. The company's EPS TTM is S$; its P/E ratio is -22.47; Biolidics Ltd. is scheduled to report earnings on April 24, 2026, and the estimated EPS forecast is S$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueS$ 5.26MS$ 784.00KS$ 277.00KS$ 2.49MS$ 2.31M
Gross ProfitS$ 1.94MS$ 187.00KS$ 146.00KS$ 1.16MS$ 483.00K
Operating IncomeS$ -3.22MS$ -1.70MS$ -996.00KS$ -3.04MS$ -3.31M
EBITDAS$ -3.65MS$ -3.03MS$ -1.16MS$ -8.50MS$ -4.58M
Net IncomeS$ -3.96MS$ -3.43MS$ -2.49MS$ -9.37MS$ -5.98M
Balance Sheet
Cash & Short-Term InvestmentsS$ 557.00KS$ 295.00KS$ 183.00KS$ 5.03MS$ 3.96M
Total AssetsS$ 5.08MS$ 4.67MS$ 682.00KS$ 6.09MS$ 11.42M
Total DebtS$ 2.41MS$ 1.75MS$ 2.02MS$ 3.01MS$ 4.25M
Net DebtS$ 1.86MS$ 1.46MS$ 1.84MS$ -2.02MS$ 289.00K
Total LiabilitiesS$ 3.56MS$ 2.94MS$ 2.67MS$ 7.78MS$ 9.09M
Stockholders' EquityS$ 1.53MS$ 1.73MS$ -1.99MS$ -1.69MS$ 2.33M
Cash Flow
Free Cash FlowS$ -360.00KS$ -2.32MS$ -1.97MS$ -3.16MS$ -5.20M
Operating Cash FlowS$ -360.00KS$ -2.31MS$ -1.97MS$ -3.06MS$ -4.64M
Investing Cash FlowS$ 0.00S$ -5.00KS$ -2.69MS$ 5.00KS$ -860.00K
Financing Cash FlowS$ 623.00KS$ 2.36MS$ -200.00KS$ 4.18MS$ -1.15M
Currency in SGD

Biolidics Ltd. Earnings and Revenue History

Income Statement >

Biolidics Ltd. Debt to Assets

Balance Sheet >

Biolidics Ltd. Cash Flow

Cash Flow >

Biolidics Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >